Trial-Based Costs Of All-Cause Adverse Events In First-Line Therapy For Advanced Non-Small Cell Lung Cancer: Findings From Checkmate-9laD. Stenehjem,S. J. Lubinga,S. B. King,K. A. Betts,S. Rao,F. Castriota,M. Mahin,E. Orvis,S. Marathe,J. MaANNALS OF ONCOLOGY(2020)引用 1|浏览10暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要